The Defense Health Agency issued a purchase order to Quidelortho Sales Company, LLC, a HUBZone-certified joint venture, for vitamin D immunoassay reagent and chemistry and immunoassay testing supplies valued at $1,126,403.12, awarded April 1, 2024. Performance occurs at Fort Johnson South, Louisiana. The order is firm fixed price with no set-aside applied. Work extends through March 31, 2029. The award originated from a Medical Readiness Contracting Office solicitation posted October 20, 2023, seeking leased Chemistry and Immunoassay Integrated Analyzers and reagent testing supplies for Bayne Jones Army Community Hospital under a cost-per-reportable-result agreement. The purchase order adds CLINs 2072, 3072, and 4072 in FY26, expanding the reagent and testing scope beyond the original base period.